Nature Communications (Sep 2018)

Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits

  • Thorunn Rafnar,
  • Bjarni Gunnarsson,
  • Olafur A. Stefansson,
  • Patrick Sulem,
  • Andres Ingason,
  • Michael L. Frigge,
  • Lilja Stefansdottir,
  • Jon K. Sigurdsson,
  • Vinicius Tragante,
  • Valgerdur Steinthorsdottir,
  • Unnur Styrkarsdottir,
  • Simon N. Stacey,
  • Julius Gudmundsson,
  • Gudny A. Arnadottir,
  • Asmundur Oddsson,
  • Florian Zink,
  • Gisli Halldorsson,
  • Gardar Sveinbjornsson,
  • Ragnar P. Kristjansson,
  • Olafur B. Davidsson,
  • Anna Salvarsdottir,
  • Asgeir Thoroddsen,
  • Elisabet A. Helgadottir,
  • Katrin Kristjansdottir,
  • Orri Ingthorsson,
  • Valur Gudmundsson,
  • Reynir T. Geirsson,
  • Ragnheidur Arnadottir,
  • Daniel F. Gudbjartsson,
  • Gisli Masson,
  • Folkert W. Asselbergs,
  • Jon G. Jonasson,
  • Karl Olafsson,
  • Unnur Thorsteinsdottir,
  • Bjarni V. Halldorsson,
  • Gudmar Thorleifsson,
  • Kari Stefansson

DOI
https://doi.org/10.1038/s41467-018-05428-6
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 9

Abstract

Read online

Uterine leiomyomas are common benign tumors. Here, a meta-analysis of two European leiomyoma GWAS uncovers 21 leiomyoma risk variants at 16 loci, providing evidence of genetic overlap between leiomyoma and various benign and malignant tumors and highlighting the role of estrogen in tumor growth.